BOP 2020 - Breast Oncology Program Retreat 2020
Feb 20 - Feb 20, 2020 | San FranciscoCAUS
LARVOL is not affiliated with Breast Oncology Program Retreat 2020 and all trademarks, logos, and brand names are property of their respective owners
Showing 7 abstracts linked to Trials
1 - Breast cancer subtype specific association of pCR with MRI assessed tumor volume progression during NAC in the I-SPY 2 TRIAL
4 - Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival
6 - Circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) for monitoring and predicting response to neoadjuvant therapy (NAT) in high-risk early breast cancer patients in the I-SPY 2 TRIAL
14 - Pazopanib (PZ) plus endocrine therapy as treatment for hormone resistant advanced breast cancer (ABC).
10 - Application of Machine Learning to elucidate the biology predicting response in the I SPY 2 neoadjuvant breast cancer trial
4 - Using a breast cancer risk model and risk thresholds as a predictor of chemoprevention uptake
5 - Personalized breast cancer screening in a population-based study: Women Informed to Screen Depending On Measures of Risk (WISDOM)